Circassia

company

About

Circassia is dedicated to point of care asthma diagnosis and management.

  • 51 - 100

Details

Last Funding Type
Series D
Last Funding Money Raised
$98M
Industries
Health Care,Medical Device
Founded date
Jan 1, 2006
Number Of Employee
51 - 100
Operating Status
Active

Circassia is a dedicated diagnostics and management company focused on asthma. Our market-leading NIOX® products are used by physicians around the world to help improve asthma diagnosis and management, and we support our customers with dedication to outstanding customer service and after sales support.
Our purpose is to improve the quality of life for millions of people suffering from asthma. As the leading provider of point-of-care FeNO diagnosis and management products we are making good progress, helping healthcare professionals manage their patients’ asthma. We believe every asthma patient should have access to the best care. To help achieve this, we are working hard to provide our customers with outstanding support, while devoting ourselves to developing the next generation of NIOX® innovations.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$98M £26.25M
Circassia has raised a total of $98M £26.25M in funding over 2 rounds. Their latest funding was raised on Apr 19, 2011 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 19, 2011 Series D $98M 1 Detail
Dec 14, 2009 Series C £15.25M 1 Detail
Jan 29, 2008 Series B £11M 1 Invesco Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Circassia is funded by 1 investors. Invesco are the most recent investors.
Investor Name Lead Investor Funding Round
Invesco Series D